BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3921382)

  • 1. Plasma oxalate concentration and oxalate distribution volume in patients with normal and decreased renal function.
    Prenen JA; Dorhout Mees EJ; Boer P
    Eur J Clin Invest; 1985 Feb; 15(1):45-9. PubMed ID: 3921382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional oxalate clearance in subjects with normal and impaired renal function.
    Boer P; Prenen JA; Koomans HA; Dorhout Mees EJ
    Nephron; 1985; 41(1):78-81. PubMed ID: 4033845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma oxalate and creatinine and oxalate/creatinine clearance ratios in normal subjects and in primary hyperoxaluria. Evidence for renal hyperoxaluria.
    Kasidas GP; Nemat S; Rose GA
    Clin Chim Acta; 1990 Oct; 191(1-2):67-77. PubMed ID: 2073734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma level and renal clearance of oxalate in normal subjects and in patients with primary hyperoxaluria or chronic renal failure or both.
    Constable AR; Joekes AM; Kasidas GP; O'Regan P; Rose GA
    Clin Sci (Lond); 1979 Apr; 56(4):299-304. PubMed ID: 477214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential studies of oxalate dynamics in primary hyperoxaluria.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1983 Dec; 65(6):627-33. PubMed ID: 6627848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxalic acid concentration in serum measured by isotopic clearance technique. Experience in hyper- and normo-oxaluric subjects.
    Prenen JA; Mees EJ; Boer P; Endeman HJ; Ephraim KH
    Proc Eur Dial Transplant Assoc; 1979; 16():566-70. PubMed ID: 549000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma oxalate concentration and renal excretion of oxalate in man.
    Hodgkinson A; Wilkinson R
    Clin Sci Mol Med; 1974 Jan; 46(1):61-73. PubMed ID: 4811877
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary oxalate and glycolate excretion and plasma oxalate concentration.
    Barratt TM; Kasidas GP; Murdoch I; Rose GA
    Arch Dis Child; 1991 Apr; 66(4):501-3. PubMed ID: 2031609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal elimination kinetics and plasma half-life of oxalate in man.
    Osswald H; Hautmann R
    Urol Int; 1979; 34(6):440-50. PubMed ID: 494445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.
    Hoppe B; Beck B; Gatter N; von Unruh G; Tischer A; Hesse A; Laube N; Kaul P; Sidhu H
    Kidney Int; 2006 Oct; 70(7):1305-11. PubMed ID: 16850020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pyridoxine on oxalate dynamics in three cases of primary hyperoxaluria (with glycollic aciduria).
    Watts RW; Veall N; Purkiss P; Mansell MA; Haywood EF
    Clin Sci (Lond); 1985 Jul; 69(1):87-90. PubMed ID: 4064559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of renal transplantation on serum oxalate and urinary oxalate excretion.
    Worcester EM; Fellner SK; Nakagawa Y; Coe FL
    Nephron; 1994; 67(4):414-8. PubMed ID: 7969673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of oxalic acid clearance and plasma concentration by radioisotope infusion. Results in a family with hyperoxaluria.
    Prenen JA; Boer P; Dorhout Mees EJ; Endeman HJ; Yoe OH
    Acta Med Scand; 1981; 209(1-2):87-91. PubMed ID: 7211493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
    Garrelfs SF; Frishberg Y; Hulton SA; Koren MJ; O'Riordan WD; Cochat P; Deschênes G; Shasha-Lavsky H; Saland JM; Van't Hoff WG; Fuster DG; Magen D; Moochhala SH; Schalk G; Simkova E; Groothoff JW; Sas DJ; Meliambro KA; Lu J; Sweetser MT; Garg PP; Vaishnaw AK; Gansner JM; McGregor TL; Lieske JC;
    N Engl J Med; 2021 Apr; 384(13):1216-1226. PubMed ID: 33789010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II involvement in adaptive enteric oxalate excretion in rats with chronic renal failure induced by hyperoxaluria.
    Hatch M; Freel RW
    Urol Res; 2003 Dec; 31(6):426-32. PubMed ID: 14574528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal excretion of oxalate in patients with chronic renal failure or nephrolithiasis.
    Chen SM; Chen TW; Lee YH; Chu WY; Young TK
    J Formos Med Assoc; 1990 Aug; 89(8):651-6. PubMed ID: 1981225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1.
    Ruder H; Otto G; Schutgens RB; Querfeld U; Wanders RJ; Herzog KH; Wölfel P; Pomer S; Schärer K; Rose GA
    Eur J Pediatr; 1990 Nov; 150(1):56-8. PubMed ID: 2079078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.
    Kasidas GP; Rose GA
    Clin Chim Acta; 1986 Jan; 154(1):49-58. PubMed ID: 3943224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparability of oxalate excretion and oxalate:creatinine ratio in the investigation of primary hyperoxaluria: review of data from a referral centre.
    Clifford-Mobley O; Tims C; Rumsby G
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):113-21. PubMed ID: 24719216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.